- Home
- ECOR vs PDSB Comparison
ECOR vs PDSB Comparison
Compare ECOR & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- PDSB
- Stock Information
- Founded
- ECOR 2005
- PDSB 2005
- Country
- ECOR United States
- PDSB United States
- Employees
- ECOR N/A
- PDSB N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- ECOR Health Care
- PDSB Health Care
- Exchange
- ECOR Nasdaq
- PDSB Nasdaq
- Market Cap
- ECOR 40.0M
- PDSB 44.5M
- IPO Year
- ECOR 2018
- PDSB N/A
- Fundamental
- Price
- ECOR $5.09
- PDSB $0.95
- Analyst Decision
- ECOR Strong Buy
- PDSB Strong Buy
- Analyst Count
- ECOR 2
- PDSB 2
- Target Price
- ECOR $25.50
- PDSB $10.00
- AVG Volume (30 Days)
- ECOR 46.6K
- PDSB 478.6K
- Earning Date
- ECOR 11-12-2025
- PDSB 11-13-2025
- Dividend Yield
- ECOR N/A
- PDSB N/A
- EPS Growth
- ECOR N/A
- PDSB N/A
- EPS
- ECOR N/A
- PDSB N/A
- Revenue
- ECOR $27,700,000.00
- PDSB N/A
- Revenue This Year
- ECOR $24.48
- PDSB N/A
- Revenue Next Year
- ECOR $44.35
- PDSB N/A
- P/E Ratio
- ECOR N/A
- PDSB N/A
- Revenue Growth
- ECOR 30.16
- PDSB N/A
- 52 Week Low
- ECOR $4.16
- PDSB $0.85
- 52 Week High
- ECOR $19.49
- PDSB $3.48
- Technical
- Relative Strength Index (RSI)
- ECOR 48.99
- PDSB 37.13
- Support Level
- ECOR $4.80
- PDSB $0.90
- Resistance Level
- ECOR $5.26
- PDSB $1.04
- Average True Range (ATR)
- ECOR 0.25
- PDSB 0.05
- MACD
- ECOR 0.03
- PDSB 0.00
- Stochastic Oscillator
- ECOR 55.17
- PDSB 30.07
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.